• 1
    Adashi E, Leung P. The ovary. Philadelphia: Lippincott Williams & Wilkins, 1993.
  • 2
    Barber HR. Embryology of the gonad with reference to special tumors of the ovary and testis. J Pediatr Surg. 1988; 23: 967972.
  • 3
    Gondos B. Development of the reproductive organs. Ann Clin Lab Sci. 1985; 15: 363373.
  • 4
    Mittwoch U. Males, females and hermaphrodites. Ann Hum Genet. 1985; 50: 103121.
  • 5
    Motta P, Makabe S, Nottola S. The ultrastructure of human reproduction. I. The natural history of the female germ cell: origin, migration and differentiation inside the developing ovary. Hum Reprod Update. 1997; 3: 281295.
  • 6
    Ostrer H. Sexual differentiation. Semin Reprod Med. 2000; 18: 4149.
  • 7
    Stenberg S. Histology for pathologists. Philadelphia: Lippincott-Raven, 1997.
  • 8
    Kurman R. Blaustein's pathology of the female genital tract. New York: Springer-Verlag, 1994.
  • 9
    Rubin SC, Sutton G. Ovarian cancer. Philadelphia: Lippincott Williams & Wilkins, 2001.
  • 10
    Scully R, Sobin L. Histological typing of ovarian tumours, volume 9. New York: Springer Berlin, 1999.
  • 11
    Scully R, Young R, Clement P. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Washington: Armed Forces Institute of Pathology, 1998.
  • 12
    Pettersson F. Annual report of the results of treatment in gynecological cancer. Stockholm: International Federation of Gynecology and Obstetrics, 1991.
  • 13
    Stalsberg H, Bjarnason O, de Carvalho ARL, et al. An international survey of distribution of histologic types of tumors of the testis and ovary. In: StalsbergH, editor. An international survey of distribution of histologic types of tumors of the testis and ovary. UICC technical report series, volume 75. Geneva: International Union Against Cancer, 1983.
  • 14
    Serov SF, Scully RE, Sobin LH. Histological typing of ovarian tumours, volume 9. Geneva: World Health Organization, 1973.
  • 15
    Parkin DM, Shanmugaratnam K, Sobin L, Ferlay J, Whelan SL. Histological groups for comparative studies, volume 31. IARC technical report. Lyon: International Agency for Research on Cancer, 1998.
  • 16
    Fritz A, Percy C, Jack A, et al. International classification of diseases for oncology, 3rd edition. Geneva: World Health Organization, 2000.
  • 17
    Rothwell DJ. Systematized nomenclature of medicine. Microglossary for surgical pathology. Northfield: College of American Pathologists, 1980.
  • 18
    FlemingID, CooperJS, HensonDE, HutterRVP, KennedyBJ, editors. American Joint Committee on Cancer (AJCC) cancer staging manual, 5th edition. Philadelphia: Lippincott-Raven, 1997.
  • 19
    Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. J Epidemiol Biostat. 2001; 6: 107138.
  • 20
    Shimizu Y, Kamoi S, Amada S, Hasumi K, Akiyama F, Silverberg SG. Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features—problems involved in the architectural grading system. Gynecol Oncol. 1998; 70: 212.
  • 21
    Silverberg SG. Histopathologic grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol. 2000; 19: 715.
  • 22
    Mayr D, Diebold J. Grading of ovarian carcinomas. Int J Gynecol Pathol. 2000; 19: 348353.
  • 23
    Garcia A, Bussaglia E, Machin P, Matias-Guiu X, Prat J. Loss of heterozygosity on chromosome 17q in epithelial ovarian tumors: association with carcinomas with serous differentiation. Int J Gynecol Pathol. 2000; 19: 152157.
  • 24
    Russell SE, McIlhatton MA, Burrows JF, et al. Isolation and mapping of a human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors. Cancer Res. 2000; 60: 47294734.
  • 25
    Baxter SW, Thomas EJ, Campbell IG. GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer. Carcinogenesis. 2001; 22: 6365.
  • 26
    Prat J. Ovarian tumors of borderline malignancy (tumors of low malignant potential): a critical appraisal. Adv Anat Pathol. 1999; 6: 247274.
  • 27
    Szych C, Staebler A, Connolly DC, Wu R, Cho KR, Ronnett BM. Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in women. Am J Pathol. 1999; 154: 18491855.
  • 28
    Aunoble B, Sanches R, Didier E, Bignon YJ. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer. Int J Oncol. 2000; 16: 567576.
  • 29
    Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst. 1998; 90: 17741786.
  • 30
    Auer G, Einhorn N, Nilsson B, Silfversward C, Sjovall K. Biological malignancy grading in early-stage ovarian carcinoma. Acta Oncol. 1996; 35: 9398.
  • 31
    Costa MJ, Walls J, Ames P, Roth LM. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior. Hum Pathol. 1996; 27: 274281.
  • 32
    Shigemasa K, Shiroyama Y, Sawasaki T, et al. Underexpression of cyclin-dependent kinase inhibitor p27 is associated with poor prognosis in serous ovarian carcinomas. Int J Oncol. 2001; 18: 953958.